- Home
- Advocacy
- Latest News and Practice Data
- White House Urges Congress to Fund Strategic National Stockpile for Future Pandemics
On March 2, the Biden Administration announced it added personal protective equipment and diagnostic tests to the Strategic National Stockpile of medical equipment and further asked Congress for related funding. In its COVID-19 response strategy report, the Administration added at-home COVID-19 tests, antivirals, and masks to the Strategic National Stockpile, but needs additional funds from Congress to increase domestic vaccine and virus test manufacturing. The CAP has encouraged the Biden Administration to prepare for future public health emergencies, including shoring up the strategic national stockpile supply chains, global and domestic vaccine manufacturing, biosecurity, and therapeutics.
The administration has sought to invest in sustained manufacturing of COVID-19 tests and vaccines that can be stockpiled in preparation for future pandemics. The funding request to Congress for scaling up domestic vaccine and test manufacturing. The Administration will also take steps to ensure that the medical device industry can rapidly scale up manufacturing capacity if needed. However, the report does not detail how many at-home tests the government hopes to put in reserve.